Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery

NCT03923556 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplant; Complications
Postoperative Residual Curarization
Postoperative Residual Weakness

Interventions

DRUG: Sugammadex
DRUG: Neostigmine

Sponsor

University of Colorado, Denver